David Kaufman, M.D.

Kaufman joined Third Rock Ventures in 2020 and has been a partner since 2022. He previously was chief medical officer and head of translational development at the Bill and Melinda Gates Medical Research Institute, and led translational oncology at Merck Research Laboratories. He is currently a director at Hookipa Pharma.

  • October 2023

Added to: Abata Therapeutics - Cambridge, MA

Abata Therapeutics is focused on translating the biology of regulatory T cells into transformational medicines for patients with severe autoimmune and inflammatory diseases.